Resultados de la búsqueda 1021-1030 of 19168 for Two-phase
... 2 or 3 meningioma as measured by 6-month PFS rate. ... ADPKD is a leading cause of end-stage renal disease. ... 2 or 3 meningioma as measured by 6-month PFS rate.
Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA ... two cycles of mosunetuzumab. An additional arm ... MC1733, Phase I Trial of Intratumoral ...
The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma ...
FTLD is a neurodegenerative disorder of the nervous system which there are no approved treatments or cures. The study has two arms: a “longitudinal arm” ...
The purpose of this study is to see if Magnetic Resonance Elastography (MRE) a recently developed imaging technique can be used to characterize and help stage ...
In the phase II part, to evaluate the preliminary antitumor activity of two different doses/regimens of [177Lu]Lu-NeoB in combination with capecitabine ...
... stage glioma tumors and evaluate response to therapy. ... The purpose of this study is to understand how electrical stimulation of the brain can modulate and ...
ADPKD is a leading cause of end-stage renal disease. ... In addition to Tier 1 procedures, at each in-person follow-up visit: Tier 2 ... ADPKD is a leading cause of ...
This randomized phase III trial compares memantine hydrochloride and whole ... 2-year progression free survival (PFS) rate as compared to ACNS0122.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?